Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


Articles published in Clin Exp Rheumatol

Retrieve available abstracts of 231 articles:
HTML format



Single Articles


    April 2022
  1. MARTIN-GONZALEZ C, Martin-Folgueras T, Quevedo-Abeledo JC, de Armas-Rillo L, et al
    Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III.
    Clin Exp Rheumatol. 2022 Apr 6. pii: 18203.
    PubMed     Abstract available


    March 2022
  2. KEYSTONE E, Movahedi M, Cesta A, Bombardier C, et al
    Differential influence of Clinical Disease Activity Index components based on disease state in rheumatoid arthritis patients: real-world results from the Ontario Best Practices Research Initiative.
    Clin Exp Rheumatol. 2022 Mar 30. pii: 17725.
    PubMed     Abstract available


  3. LIN T, Xu S, Wang Y, Nian X, et al
    Human epididymis protein 4 as a new diagnostic biomarker for rheumatoid arthritis-associated interstitial lung disease.
    Clin Exp Rheumatol. 2022 Mar 23. pii: 18186.
    PubMed     Abstract available


  4. KLEMM P, Hoffmann J, Asendorf T, Aykara I, et al
    Whole-body cryotherapy for the treatment of rheumatoid arthritis: a monocentric, single-blinded, randomised controlled trial.
    Clin Exp Rheumatol. 2022 Mar 1. pii: 17706.
    PubMed     Abstract available


  5. PETRELLI F, Mariani FM, Alunno A, Puxeddu I, et al
    Pathogenesis of rheumatoid arthritis: one year in review 2022.
    Clin Exp Rheumatol. 2022;40:475-482.
    PubMed     Abstract available


  6. HUANG T, Li Y, Luo Y, Zhou Y, et al
    Research progress on the pathogenesis and quality of life of patients with primary Sjogren's syndrome complicated by depression.
    Clin Exp Rheumatol. 2022;40:647-654.
    PubMed     Abstract available


    February 2022
  7. VERHOEVEN MMA, Westgeest AAA, Tekstra J, van Laar JM, et al
    Classification of rheumatoid arthritis into active or inactive with a modified Disease Activity score, for future use as a treat-to-target tool, with a HandScan score replacing joint counts.
    Clin Exp Rheumatol. 2022 Feb 17. pii: 17657.
    PubMed     Abstract available


  8. KANG JH, Choi SE, Xu H, Park DJ, et al
    Non-adherence to methotrexate was associated with high disease activity and poor health-related outcomes during a 4-year follow-up of rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2022 Feb 17. pii: 17574.
    PubMed     Abstract available


  9. NODA K, Saitou M, Matsushita T, Ukichi T, et al
    How do central sensitisation features affect symptoms among patients with rheumatoid arthritis? Analysis of pain descriptors and the effect of central sensitivity syndrome on patient and evaluator global assessments.
    Clin Exp Rheumatol. 2022 Feb 1. pii: 17676.
    PubMed     Abstract available


  10. WU B, Peng R, Chen Y, Zhong J, et al
    Identification of RRM2 in peripheral blood mononuclear cells as a novel biomarker for the diagnosis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Feb 1. pii: 17730.
    PubMed     Abstract available


  11. MURRAY MT, Penney SP, Landman A, Elias J, et al
    User experience with a voice-enabled smartphone app to collect patient-reported outcomes in rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Feb 1. pii: 16841.
    PubMed     Abstract available


    January 2022
  12. HIROHATA S, Nagai T, Tomita T
    Enhanced expression of mRNA for transforming growth factor beta activated kinase 1 in CD34+ cells of the bone marrow in rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Jan 27. pii: 17941.
    PubMed     Abstract available


  13. MASNERI S, Piantoni S, Galoppini G, Regola F, et al
    CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept.
    Clin Exp Rheumatol. 2022 Jan 27. pii: 17712.
    PubMed     Abstract available


  14. KALYONCU U, Bilgin E, Erden A, Satis H, et al
    Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data.
    Clin Exp Rheumatol. 2022 Jan 25. pii: 17973.
    PubMed     Abstract available


  15. TAKASHIMA Y, Hayashi S, Maeda T, Fukuda K, et al
    Histopathological changes of synovial tissue in rheumatoid arthritis patients treated with TNF-alpha inhibitors or IL-6 inhibitors.
    Clin Exp Rheumatol. 2022 Jan 25. pii: 17785.
    PubMed     Abstract available


  16. SMITH ID, Lu N, Wei J, Zhang Y, et al
    Alcohol consumption and the risk of mortality and myocardial infarction in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2022 Jan 25. pii: 17761.
    PubMed     Abstract available


  17. FORNARO M, Benaglio F, Montecucco C, Raffeiner B, et al
    Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of t
    Clin Exp Rheumatol. 2022 Jan 12. pii: 17698.
    PubMed     Abstract available


  18. NOVELLA-NAVARRO M, Genre F, Hernandez-Breijo B, Remuzgo-Martinez S, et al
    Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines.
    Clin Exp Rheumatol. 2022 Jan 12. pii: 17782.
    PubMed     Abstract available


  19. ISSA SF, Lindegaard HM, Lorenzen T, Junker K, et al
    Erratum corrige: Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.
    Clin Exp Rheumatol. 2022;40:198.
    PubMed    


    December 2021
  20. PODGORSKA D, Ciesla M, Majdan M, Podgorski R, et al
    The relationship of ADAMTSL2 and LRPAP1 gene methylation level with rheumatoid arthritis activity.
    Clin Exp Rheumatol. 2021 Dec 22. pii: 17757.
    PubMed     Abstract available


    November 2021
  21. MODARRESI CHAHARDEHI A, Masoumi SA, Bigdeloo M, Arsad H, et al
    The effect of exercise on patients with rheumatoid arthritis on the modulation of inflammation.
    Clin Exp Rheumatol. 2021 Nov 23. pii: 17457.
    PubMed     Abstract available


  22. SPECKER C, Aringer M, Burmester GR, Killy B, et al
    The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with age.
    Clin Exp Rheumatol. 2021 Nov 22. pii: 17272.
    PubMed     Abstract available


  23. LAYEGH Z, Hooijberg F, Bastida C, Huitema ADR, et al
    Is there a potential for therapeutic drug monitoring of subcutaneously administered tocilizumab in patients with rheumatoid arthritis in daily practice?
    Clin Exp Rheumatol. 2021 Nov 3. pii: 17173.
    PubMed    


  24. SUGAWARA M, Fujieda Y, Noguchi A, Tanimura S, et al
    Prediction of the intolerance or non-responder to Janus kinase inhibitors in patients with rheumatoid arthritis: a preliminary retrospective study with integrative cluster analysis.
    Clin Exp Rheumatol. 2021 Nov 3. pii: 17548.
    PubMed     Abstract available


  25. ALDRIDGE J, Lundell AC, Andersson K, Mark L, et al
    Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Nov 3. pii: 17505.
    PubMed     Abstract available


  26. BEN-CHETRIT E, Ben-Chetrit E
    Palindromic rheumatism following COVID-19 infection evolved to rheumatoid arthritis after COVID-19 reinfection.
    Clin Exp Rheumatol. 2021;39:1410-1412.
    PubMed     Abstract available


  27. CHOWDHURY F, Grigoriadou S, Bombardieri M
    Severity of COVID-19 infection in primary Sjogren's syndrome and the emerging evidence of COVID-19-induced xerostomia.
    Clin Exp Rheumatol. 2021;39 Suppl 133:215-222.
    PubMed     Abstract available


  28. RETAMOZO S, Acar-Denizli N, Horvath IF, Ng WF, et al
    Influence of the age at diagnosis in the disease expression of primary Sjogren syndrome. Analysis of 12,753 patients from the Sjogren Big Data Consortium.
    Clin Exp Rheumatol. 2021;39 Suppl 133:166-174.
    PubMed     Abstract available


  29. DUBOST JJ, Couderc M, Pereira B, Mariette X, et al
    Concomitant fibromyalgia in primary Sjogren's syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician's opinion.
    Clin Exp Rheumatol. 2021;39 Suppl 133:140-145.
    PubMed     Abstract available


  30. LOUREIRO-AMIGO J, Franco-Jarava C, Perurena-Prieto J, Palacio C, et al
    Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:131-139.
    PubMed     Abstract available


  31. CAFARO G, Bursi R, Chatzis LG, Fulvio G, et al
    One year in review 2021: Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:3-13.
    PubMed     Abstract available


  32. SISO-ALMIRALL A, Meijer JM, Brito-Zeron P, Conangla L, et al
    Practical guidelines for the early diagnosis of Sjogren's syndrome in primary healthcare.
    Clin Exp Rheumatol. 2021;39 Suppl 133:197-205.
    PubMed     Abstract available


  33. CARUBBI F, Alunno A, Mai F, Mercuri A, et al
    Adherence to the Mediterranean diet and the impact on clinical features in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:190-196.
    PubMed     Abstract available


  34. SEGHIERI C, Lupi E, Tzioufas AG, De Vita S, et al
    Patient-reported experience and health-related quality of life in patients with primary Sjogren's syndrome in Europe.
    Clin Exp Rheumatol. 2021;39 Suppl 133:123-130.
    PubMed     Abstract available


  35. BRITO-ZERON P, Acar-Denizli N, Romao VC, Armagan B, et al
    Post-COVID-19 syndrome in patients with primary Sjogren's syndrome after acute SARS-CoV-2 infection.
    Clin Exp Rheumatol. 2021;39 Suppl 133:57-65.
    PubMed     Abstract available


  36. KOH JH, Park Y, Lee J, Park SH, et al
    Hypergammaglobulinaemia predicts glandular and extra-glandular damage in primary Sjogren's syndrome: results from the KISS cohort study.
    Clin Exp Rheumatol. 2021;39 Suppl 133:114-122.
    PubMed     Abstract available


  37. LEGGER GE, Erdtsieck MB, de Wolff L, Stel AJ, et al
    Differences in presentation between paediatric- and adult-onset primary Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2021;39 Suppl 133:85-92.
    PubMed     Abstract available


  38. ZHANG X, Zhang S, Feng R, Yao H, et al
    Sonoelastography of salivary glands for diagnosis and clinical evaluation in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:184-189.
    PubMed     Abstract available


  39. DE WOLFF L, Arends S, Pontarini E, Bombardieri M, et al
    Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:100-106.
    PubMed     Abstract available


  40. BEJARANO MV, Romanini F, Catalan Pellet A, Mamani MN, et al
    Work productivity and activity impairment in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:93-99.
    PubMed     Abstract available


  41. CHATZIS LG, Goules AV, Tzioufas AG
    Searching for the "X factor" in Sjogren's syndrome female predilection.
    Clin Exp Rheumatol. 2021;39 Suppl 133:206-214.
    PubMed     Abstract available


  42. LORENZON M, Tulipano Di Franco F, Zabotti A, Pegolo E, et al
    Sonographic features of lymphoma of the major salivary glands diagnosed with ultrasound-guided core needle biopsy in Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:175-183.
    PubMed     Abstract available


  43. FARENHORST CA, de Wolff L, Arends S, van Nimwegen JF, et al
    Clinical determinants of vaginal dryness in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:73-79.
    PubMed     Abstract available


  44. PRINGLE SA, Berkhof B, van Ginkel M, Liefers S, et al
    Parotid salivary sodium levels of Sjogren's syndrome patients suggest B-cell mediated epithelial sodium channel disruption.
    Clin Exp Rheumatol. 2021;39 Suppl 133:30-38.
    PubMed     Abstract available


  45. CHATZIS LG, Pezoulas V, Voulgari PV, Baldini C, et al
    Combined seronegativity in Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:80-84.
    PubMed     Abstract available


  46. GOZUKUCUK M, Turkyilmaz E, Kucuksahin O, Erten S, et al
    Effects of primary Sjogren's syndrome on female genitalia and sexual functions.
    Clin Exp Rheumatol. 2021;39 Suppl 133:66-72.
    PubMed     Abstract available


  47. PENG X, Lu Y, Wei J, Lin T, et al
    A cohort study of T helper 17 cell-related cytokine levels in tear samples of systemic lupus erythematosus and Sjogren's syndrome patients with dry eye disease.
    Clin Exp Rheumatol. 2021;39 Suppl 133:159-165.
    PubMed     Abstract available


  48. COLEBY R, Lucchesi D, Pontarini E, Pitzalis C, et al
    Stepwise changes in the murine salivary gland immune response during virally-induced ectopic lymphoid structure formation.
    Clin Exp Rheumatol. 2021;39 Suppl 133:39-48.
    PubMed     Abstract available


  49. HERNANDEZ-MOLINA G, Soto-Abraham V, Zamora-Legoff V, Furuzawa-Carballeda J, et al
    Differential Th follicular cell subsets in minor salivary glands of patients with primary Sjogren's syndrome and systemic lupus erythematosus associated with Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:49-56.
    PubMed     Abstract available


  50. RAMOS-CASALS M, Sainz-de-la-Maza M, Muxi A
    COVID-19 vaccination unveiling subclinical Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:228-229.
    PubMed    


  51. XU T, Guo Y, Lu J, Shan J, et al
    Untargeted serum metabolomics and potential biomarkers for Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:23-29.
    PubMed     Abstract available


  52. SANDOVAL-FLORES MG, Chan-Campos I, Hernandez-Molina G
    Factors influencing the EULAR Sjogren's Syndrome Patient-Reported Index in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39 Suppl 133:153-158.
    PubMed     Abstract available


  53. KOMORI K, Komori M, Horino T, Nishiyama S, et al
    Factors associated with delayed diagnosis of Sjogren's syndrome among members of the Japanese Sjogren's Association for Patients.
    Clin Exp Rheumatol. 2021;39 Suppl 133:146-152.
    PubMed     Abstract available


  54. GUNDOGUS B, Yildiz T, Agca M, Erdagi A, et al
    Sjogren's syndrome and pulmonary alveolar proteinosis co-existence.
    Clin Exp Rheumatol. 2021;39 Suppl 133:230.
    PubMed    


  55. LANG J, Shi X, Ma Y, Zou L, et al
    Primary Sjogren's syndrome with minimal change disease: case series and literature review.
    Clin Exp Rheumatol. 2021;39 Suppl 133:226-227.
    PubMed    


  56. JAGER-WITTENAAR H, Vissink A, Kroese FGM, Bootsma H, et al
    Undernutrition and sarcopenic obesity: underrecognised conditions in patients with Sjogren's syndrome?
    Clin Exp Rheumatol. 2021;39 Suppl 133:20-22.
    PubMed    


  57. VIEIRA A, Grosjean A, Stone L, Oosterbaan M, et al
    Sjogren's: the European patients' community perspective.
    Clin Exp Rheumatol. 2021;39 Suppl 133:14-16.
    PubMed    


  58. GENET L, Jalladaud M, Seror R, Gosset M, et al
    Plasma cell gingivitis, an underestimated condition in patients with Sjogren's syndrome?
    Clin Exp Rheumatol. 2021;39 Suppl 133:225.
    PubMed    


  59. IZUKA S, Yamashita H, Takahashi Y, Kaneko H, et al
    Type II cryoglobulinaemic vasculitis with primary Sjogren's syndrome successfully treated with belimumab and hydroxychloroquine.
    Clin Exp Rheumatol. 2021;39 Suppl 133:223-224.
    PubMed    


    October 2021
  60. CAFARO G, Perricone C, Riccucci I, Bursi R, et al
    Traditional and disease-related non-computed variables affect algorithms for cardiovascular risk estimation in Sjogren's syndrome and rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Oct 18. pii: 17870.
    PubMed     Abstract available


    September 2021
  61. KLEMM P, Preusler P, Hudowenz O, Asendorf T, et al
    Effects of multimodal rheumatologic complex treatment in patients with rheumatoid arthritis: a monocentric prospective study.
    Clin Exp Rheumatol. 2021 Sep 28. pii: 17318.
    PubMed     Abstract available


  62. THOMPSON AE, Pope JE
    The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Sep 21. pii: 17449.
    PubMed     Abstract available


  63. RODRIGUEZ-MUGURUZA S, Combe B, Guillemin F, Fautrel B, et al
    Trajectories in early rheumatoid arthritis related fatigue over 10 years: results from the ESPOIR cohort.
    Clin Exp Rheumatol. 2021 Sep 21. pii: 17302.
    PubMed     Abstract available


  64. ZHENG B, Soares de Moura C, Machado M, Pineau CA, et al
    Association between chronic obstructive pulmonary disease, smoking, and interstitial lung disease onset in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Sep 7. pii: 17256.
    PubMed     Abstract available


  65. PERNIOLA S, Bizzoca R, Fornaro M, Alivernini S, et al
    High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study.
    Clin Exp Rheumatol. 2021 Sep 7. pii: 16999.
    PubMed     Abstract available


  66. DURAN E, Yildirim BES, Karadag O
    Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis by Humby et al.
    Clin Exp Rheumatol. 2021 Sep 7. pii: 17387.
    PubMed    


  67. MARIOTTE A, Bernardi L, Macquin C, DeCauwer A, et al
    NKG2D ligands in inflammatory joint diseases: analysis in human samples and mouse models.
    Clin Exp Rheumatol. 2021;39:982-987.
    PubMed     Abstract available


  68. YAO H, Wang Y, Wang Z, Zhao J, et al
    The performance of the diagnostic scoring system or criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis for adult-onset Still's disease. A multicentre case-control study in China.
    Clin Exp Rheumatol. 2021;39 Suppl 132:129-134.
    PubMed     Abstract available


  69. YANG CA, Chen PK, Lan JL, Chang CK, et al
    Expression signature of inflammation-associated long non-coding RNAs in adult-onset Still's disease.
    Clin Exp Rheumatol. 2021;39 Suppl 132:67-74.
    PubMed     Abstract available


  70. GAO Q, Yuan Y, Wang Y, Jiang J, et al
    Clinical characteristics of macrophage activation syndrome in adult-onset Still's disease.
    Clin Exp Rheumatol. 2021;39 Suppl 132:59-66.
    PubMed     Abstract available


  71. AIZAKI Y, Yazawa H, Sato K, Mimura T, et al
    Dual effects of interleukin-10 on natural killer cells and monocytes and the implications for adult-onset Still's disease.
    Clin Exp Rheumatol. 2021;39 Suppl 132:22-29.
    PubMed     Abstract available


  72. YAMAMOTO S, Nishimura K, Yo K, Waki D, et al
    Flare-up of adult-onset Still's disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine.
    Clin Exp Rheumatol. 2021;39 Suppl 132:139-140.
    PubMed    


    August 2021
  73. KITAMURA N, Sugiyama K, Nagasawa Y, Hamaguchi M, et al
    Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Aug 5. pii: 17140.
    PubMed     Abstract available


    July 2021
  74. CIESLA M, Kolarz B, Majdan M, Darmochwal-Kolarz D, et al
    Plasma micro-RNA-22 is associated with disease activity in well-established rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jul 24. pii: 16995.
    PubMed     Abstract available


  75. LEE K, Min HK, Koh SH, Lee SH, et al
    Prognostic signature of interferon-gamma and interleurkin-17A in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jul 23. pii: 17190.
    PubMed     Abstract available


  76. YOSHIZAWA Y, Nakao T, Tsuritani K, Yamada T, et al
    The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jul 8. pii: 16877.
    PubMed     Abstract available


  77. PULITO-CUETO V, Remuzgo-Martinez S, Genre F, Calvo-Alen J, et al
    Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy.
    Clin Exp Rheumatol. 2021 Jul 7. pii: 17208.
    PubMed     Abstract available


  78. MATSUNO H, Kang YM, Okada M, Lee SI, et al
    Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study.
    Clin Exp Rheumatol. 2021 Jul 7. pii: 16868.
    PubMed     Abstract available


  79. SILVAGNI E, Sakellariou G, Bortoluzzi A, Giollo A, et al
    One year in review 2021: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2021;39:705-720.
    PubMed     Abstract available


  80. MONA M, Mondello S, Hyon JY, Saleh W, et al
    Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39:795-803.
    PubMed     Abstract available


  81. LORAND V, Nagy G, Balint Z, Komjati D, et al
    Sensitivity to change of joint count composite indices in 72 patients with systemic sclerosis.
    Clin Exp Rheumatol. 2021;39 Suppl 131:77-84.
    PubMed     Abstract available


    June 2021
  82. ALVARO GRACIA JM, Barbazan C, Garcia Llorente JF, Munoz-Fernandez S, et al
    Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jun 26. pii: 17046.
    PubMed     Abstract available


  83. CACCIAPAGLIA F, Renna D, Fornaro M, Venerito V, et al
    Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre.
    Clin Exp Rheumatol. 2021 Jun 25. pii: 16172.
    PubMed    


  84. BOLETO G, Cren JB, Avouac J, Allanore Y, et al
    Successful treatment with baricitinib of refractory arthritis in a patient with severe diffuse cutaneous systemic sclerosis-rheumatoid arthritis overlap syndrome.
    Clin Exp Rheumatol. 2021 Jun 15. pii: 17277.
    PubMed    


  85. PIARULLI A, Conversano C, Ciacchini R, Miniati M, et al
    Catastrophisation, chronic pain and sexuality: a cross-sectional investigation in fibromyalgia and rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jun 10. pii: 17303.
    PubMed     Abstract available


  86. SAITOU M, Noda K, Matsushita T, Ukichi T, et al
    Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory.
    Clin Exp Rheumatol. 2021 Jun 8. pii: 17108.
    PubMed     Abstract available


  87. RAMIREZ J, Azuaga-Pinango AB, Frade-Sosa B, Gumucio-Sanguino R, et al
    Proliferative synovitis, an ultrasound pattern associated with ACPA-positive patients and erosive disease in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jun 8. pii: 16966.
    PubMed     Abstract available


    May 2021
  88. WINTHROP KL, Tanaka Y, Lee EB, Wollenhaupt J, et al
    Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review.
    Clin Exp Rheumatol. 2021 May 28. pii: 16343.
    PubMed     Abstract available


  89. BEHRENS F, Burmester GR, Feuchtenberger M, Kellner H, et al
    Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care.
    Clin Exp Rheumatol. 2021 May 14. pii: 16554.
    PubMed     Abstract available


  90. THALMANN R, von Kempis J, Zgraggen A, Graf N, et al
    Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high worsening of patient-related outcomes.
    Clin Exp Rheumatol. 2021 May 5. pii: 16889.
    PubMed     Abstract available


  91. TESTA D, Calvacchi S, Petrelli F, Giannini D, et al
    One year in review 2021: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2021;39:445-452.
    PubMed     Abstract available


  92. KONDO Y, Kaneko Y, Takei H, Tamai H, et al
    COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease.
    Clin Exp Rheumatol. 2021;39:631-638.
    PubMed     Abstract available


  93. DITTO MC, Parisi S, Varisco V, Talotta R, et al
    Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy.
    Clin Exp Rheumatol. 2021;39:546-554.
    PubMed     Abstract available


  94. IANNUCCELLI C, Lucchino B, Gioia C, Dolcini G, et al
    Mental health and well-being during the COVID-19 pandemic: stress vulnerability, resilience and mood disturbances in fibromyalgia and rheumatoid arthritis.
    Clin Exp Rheumatol. 2021;39 Suppl 130:153-160.
    PubMed     Abstract available


  95. ALMIRALL M, Martinez-Mateu SH, Alegre C, Collado A, et al
    Dietary habits in patients with fibromyalgia: a cross-sectional study.
    Clin Exp Rheumatol. 2021;39 Suppl 130:170-173.
    PubMed     Abstract available


    April 2021
  96. RETUERTO M, Trujillo E, Valero C, Fernandez-Espartero C, et al
    Efficacy and safety of switching Jak inhibitors in rheumatoid arthritis: an observational study.
    Clin Exp Rheumatol. 2021 Apr 27. pii: 17091.
    PubMed     Abstract available


  97. AVOUAC J, Degrave R, Vergneault H, Combier A, et al
    Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index.
    Clin Exp Rheumatol. 2021 Apr 23. pii: 16697.
    PubMed     Abstract available


  98. DI CARLO M, Tardella M, Filippucci E, Carotti M, et al
    Lung ultrasound in patients with rheumatoid arthritis: definition of significant interstitial lung disease.
    Clin Exp Rheumatol. 2021 Apr 23. pii: 16655.
    PubMed     Abstract available


    March 2021
  99. PERTSINIDOU E, Manivel VA, Westerlind H, Klareskog L, et al
    Rheumatoid arthritis autoantibodies and their association with age and sex.
    Clin Exp Rheumatol. 2021 Mar 30. pii: 16843.
    PubMed     Abstract available


  100. HASSELI R, Pfeil A, Hoyer BF, Krause A, et al
    Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
    Clin Exp Rheumatol. 2021 Mar 30. pii: 16822.
    PubMed     Abstract available


  101. PATLAN M, Paez A, Masso F, Amezcua-Guerra LM, et al
    Relative increase of Th17 phenotype in senescent CD4+CD28null T cells from peripheral blood of patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Mar 30. pii: 16892.
    PubMed    


  102. PONCHEL F, Churchman S, El-Jawhari JJ, Burska AN, et al
    Interleukin-7: a supporting factor supporting B-cell maturation in the rheumatoid arthritis synovium.
    Clin Exp Rheumatol. 2021 Mar 21. pii: 13451.
    PubMed     Abstract available


  103. VANDEN BULCKE M, Vanhaecke A, Deschepper E, Cutolo M, et al
    Laser speckle contrast analysis in rheumatoid arthritis: a pilot study.
    Clin Exp Rheumatol. 2021 Mar 9. pii: 16595.
    PubMed     Abstract available


  104. PIANTONI S, Bazzani C, Garrafa E, Fredi M, et al
    Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al.
    Clin Exp Rheumatol. 2021 Mar 5. pii: 16920.
    PubMed    


  105. CASTELLANOS-MOREIRA R, Gomez A, Haro I, Ruiz-Esquide V, et al
    Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis. Comment on: Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept.
    Clin Exp Rheumatol. 2021 Mar 3. pii: 16603.
    PubMed    


  106. RUSCITTI P, Berardicurti O, Cipriani P, Giacomelli R, et al
    Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial.
    Clin Exp Rheumatol. 2021 Mar 3. pii: 16350.
    PubMed     Abstract available


  107. AGCA R, van Sijl AM, Vosslamber S, Voskuyl AE, et al
    Interferon regulatory factor 5 gene variants rs2004640 and rs4728142 are associated with carotid intima media thickness but not with cardiovascular events in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Mar 2. pii: 16710.
    PubMed     Abstract available


  108. WANG X, Zhu G, Ren Q, Wu J, et al
    Increased interleukin-11 associated with disease activity and development of interstitial lung disease in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Mar 2. pii: 16647.
    PubMed     Abstract available


  109. ZHAO X, Gan Y, Jin Y, He J, et al
    Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39:378-384.
    PubMed     Abstract available


  110. CAMPOCHIARO C, Tomelleri A, Galli E, Cocchiara E, et al
    Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap?
    Clin Exp Rheumatol. 2021;39 Suppl 129:129-134.
    PubMed     Abstract available


    February 2021
  111. FAZELI MS, Khaychuk V, Wittstock K, Han X, et al
    Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk/prognostic factors, and treatment landscape.
    Clin Exp Rheumatol. 2021 Feb 26. pii: 16688.
    PubMed     Abstract available


  112. WAHLIN B, Ramnemark A, Rantapaa-Dahlqvist S, Wallberg-Jonsson S, et al
    Osteoprotegerin and osteocalcin are associated with atherosclerosis in patients with rheumatoid arthritis: a prospective cohort study.
    Clin Exp Rheumatol. 2021 Feb 25. pii: 16340.
    PubMed     Abstract available


  113. MERINO M, Ivanova Y, Martin Lorenzo T, Hidalgo-Vega A, et al
    Improving rheumatoid arthritis management within the Spanish National Health System: a social return on investment study.
    Clin Exp Rheumatol. 2021 Feb 15. pii: 16431.
    PubMed     Abstract available


  114. OCHI S, Mizoguchi F, Nakano K, Tanaka Y, et al
    Difficult-to-treat rheumatoid arthritis with respect to responsiveness to biologic/targeted synthetic DMARDs: a retrospective cohort study from the FIRST registry.
    Clin Exp Rheumatol. 2021 Feb 15. pii: 16267.
    PubMed     Abstract available


  115. TANG J, Lin J, Yu Z, Jiang R, et al
    Identification of circulating miR-22-3p and let-7a-5p as novel diagnostic biomarkers for rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Feb 9. pii: 16601.
    PubMed     Abstract available


  116. JUNG SM, Park KS, Kim KJ
    Clinical phenotype with high risk for initiation of biologic therapy in rheumatoid arthritis: a data-driven cluster analysis.
    Clin Exp Rheumatol. 2021 Feb 9. pii: 16046.
    PubMed     Abstract available


    January 2021
  117. SHOUVAL A, Lidar M, Reitblat T, Zisman D, et al
    Real-world effectiveness of tofacitinib in patients with rheumatoid arthritis: a prospective observational study.
    Clin Exp Rheumatol. 2021 Jan 10. pii: 15901.
    PubMed     Abstract available


  118. GIBSON DS, McGeough CM, Watterson S, Blayney J, et al
    Anti-tumour necrosis factor-alpha response associated with combined CD226 and HLA-DRB1*0404 haplotype in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jan 8. pii: 15305.
    PubMed     Abstract available


  119. DE LORENZIS E, Crudo F, Fedele AL, Fiorita A, et al
    Postural control and disability in patients with early rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jan 7. pii: 16434.
    PubMed     Abstract available


  120. HUANG F, Liu X, Cheng Y, Sun X, et al
    Antibody to peptidoglycan recognition protein (PGLYRP)-2 as a novel biomarker in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jan 6. pii: 15708.
    PubMed     Abstract available


  121. GIACOMELLI R, Sota J, Ruscitti P, Campochiaro C, et al
    The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature.
    Clin Exp Rheumatol. 2021;39:187-195.
    PubMed     Abstract available


  122. ZHAO L, Xu W, Chen Z, Zhang H, et al
    Aberrant distribution of CD3+CD56+ NKT-like cells in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39:98-104.
    PubMed     Abstract available


  123. BANDINELLI F, Benucci M, Salaffi F, Manetti M, et al
    Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales?
    Clin Exp Rheumatol. 2021;39:79-83.
    PubMed     Abstract available


    December 2020
  124. BENAGLIO F, Fornaro M, Montecucco C, Raffeiner B, et al
    Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology.
    Clin Exp Rheumatol. 2020 Dec 18. pii: 16077.
    PubMed     Abstract available


  125. GUIDELLI GM, Viapiana O, Luciano N, De Santis M, et al
    Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study.
    Clin Exp Rheumatol. 2020 Dec 18. pii: 15729.
    PubMed     Abstract available


  126. GENERALI E, De Santis M, Isailovic N, Palermo B, et al
    Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Dec 18. pii: 14773.
    PubMed     Abstract available


  127. SPINELLI FR, Ceccarelli F, Garufi C, Duca I, et al
    Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience.
    Clin Exp Rheumatol. 2020 Dec 18. pii: 15265.
    PubMed     Abstract available


  128. ALOUSH V, Niv D, Ablin JN, Yaish I, et al
    Good pain, bad pain: illness perception and physician attitudes towards rheumatoid arthritis and fibromyalgia patients.
    Clin Exp Rheumatol. 2020 Dec 15. pii: 16083.
    PubMed     Abstract available


  129. RUSCITTI P, Cipriani P, Liakouli V, Iacono D, et al
    Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study.
    Clin Exp Rheumatol. 2020 Dec 4. pii: 15967.
    PubMed     Abstract available


  130. MENG Q, Pan B, Sheng P
    Histone deacetylase 1 is increased in rheumatoid arthritis synovium and promotes synovial cell hyperplasia and synovial inflammation in the collagen-induced arthritis mouse model via the microRNA-124-dependent MARCKS-JAK/STAT axis.
    Clin Exp Rheumatol. 2020 Dec 4. pii: 15685.
    PubMed     Abstract available


    November 2020
  131. WANG H, Fang K, Wang J, Chang X, et al
    Metabolomic analysis of synovial fluids from rheumatoid arthritis patients using quasi-targeted liquid chromatography-mass spectrometry/mass spectrometry.
    Clin Exp Rheumatol. 2020 Nov 22. pii: 16235.
    PubMed     Abstract available


  132. BURMESTER GR, Alvaro-Gracia JM, Betteridge N, Calvo Alen J, et al
    Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools.
    Clin Exp Rheumatol. 2020;38:1056-1067.
    PubMed     Abstract available


  133. MORENO-FRESNEDA P, Triguero-Martinez A, Olivas-Martinez I, Ortiz-Aljaro P, et al
    Lower frequency of anti-citrullinated protein antibodies among early arthritis patients with high body mass index.
    Clin Exp Rheumatol. 2020;38:1155-1160.
    PubMed     Abstract available


  134. ZHANG YM, Liang L, Yang HB, Shu XM, et al
    Identification of a novel autoantibody against heat shock factor 1 in idiopathic inflammatory myopathy.
    Clin Exp Rheumatol. 2020;38:1191-1200.
    PubMed     Abstract available


    October 2020
  135. CRISPINO N, Ciccia F
    JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis.
    Clin Exp Rheumatol. 2020 Oct 30. pii: 15460.
    PubMed     Abstract available


  136. MARINOU D, Katsifis G, Barouta G, Liaskos C, et al
    Major vault protein/lung resistance related protein: a novel biomarker for rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Oct 29. pii: 15829.
    PubMed     Abstract available


  137. WANG Q, Fan Z, Li J, Fu L, et al
    Systematic analysis of the molecular mechanisms of methotrexate therapy for rheumatoid arthritis using text mining.
    Clin Exp Rheumatol. 2020 Oct 17. pii: 15116.
    PubMed     Abstract available


  138. WU S, Jiang Y, Teng Y, Liu X, et al
    Interleukin-33 promotes proliferation and inhibits apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Oct 9. pii: 15152.
    PubMed     Abstract available


    September 2020
  139. ZHANG H, Zhang H, Gao D, Zhang Z, et al
    Compromised ultrasound remission, functional ability and clinical decision associated with overlapping Sjogren's syndrome in rheumatoid arthritis patients: results from a propensity-score matched cohort from 2009 to 2019.
    Clin Exp Rheumatol. 2020 Sep 23. pii: 15915.
    PubMed     Abstract available


  140. MOERMAN RV, Arends S, Mossel E, Kroeze FGM, et al
    10-year follow-up of patients with rheumatoid arthritis and secondary Sjogren's syndrome or sicca symptoms in daily clinical practice.
    Clin Exp Rheumatol. 2020 Sep 23. pii: 15517.
    PubMed     Abstract available


  141. HU F, Tang Y, Wang P, Bai M, et al
    Endoplasmic reticulum stress perpetuated toll-like receptor signalling-mediated inflammation in rheumatoid arthritis via X-box-binding protein-1.
    Clin Exp Rheumatol. 2020 Sep 8. pii: 15104.
    PubMed     Abstract available


  142. KIMYON G, Kalyoncu U, Kiraz S, Bes C, et al
    Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data.
    Clin Exp Rheumatol. 2020 Sep 4. pii: 15556.
    PubMed     Abstract available


  143. LUKAS C, Redondin M, Pane I, Soubrier M, et al
    Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry.
    Clin Exp Rheumatol. 2020 Sep 3. pii: 15461.
    PubMed     Abstract available


  144. WAHLIN B, Fasth AER, Karp K, Lejon K, et al
    Atherosclerosis in rheumatoid arthritis: associations between anti-cytomegalovirus IgG antibodies, CD4+CD28null T-cells, CD8+CD28null T-cells and intima-media thickness.
    Clin Exp Rheumatol. 2020 Sep 3. pii: 15322.
    PubMed     Abstract available


  145. LOPEZ-CORBETO M, Martinez-Mateu S, Pluma A, Ferrer R, et al
    The ovarian reserve as measured by the anti-Mullerian hormone is not diminished in patients with rheumatoid arthritis compared to the healthy population.
    Clin Exp Rheumatol. 2020 Sep 3. pii: 15254.
    PubMed     Abstract available


  146. SARAUX A, Combe B, Fagnani F, Cukierman G, et al
    Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study.
    Clin Exp Rheumatol. 2020 Sep 1. pii: 15099.
    PubMed     Abstract available


  147. SUMIYOSHI R, Hidaka T, Koga T, Okada A, et al
    Rheumatoid arthritis patients with low baseline Health Assessment Questionnaire scores have a risk of functional disability progression: a post hoc analysis of a nationwide longitudinal cohort in Japan.
    Clin Exp Rheumatol. 2020 Sep 1. pii: 14994.
    PubMed     Abstract available


  148. VERHEUL MK, Janssen GMC, de Ru A, Stoeken-Rijsbergen G, et al
    Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls.
    Clin Exp Rheumatol. 2020 Sep 1. pii: 14886.
    PubMed     Abstract available


  149. LUO Q, Zhang L, Xiong L, Fu B, et al
    Peripheral blood circular RNA hsa_circ_0082688-hsa_circ_0008675 can be used as a candidate biomarker of systemic lupus erythematosus with renal involvement.
    Clin Exp Rheumatol. 2020;38:822-833.
    PubMed     Abstract available


  150. SMERILLI G, Castell S, Cipolletta E, Farah S, et al
    Ultrasound measurement of muscle thickness at the proximal forearm in a rheumatologic setting.
    Clin Exp Rheumatol. 2020;38:985-988.
    PubMed     Abstract available


  151. NAKAMURA H, Fujieda Y, Tarumi M, Kitakawa H, et al
    Calcineurin inhibitors for adult-onset Still's disease: a multicentre retrospective cohort study.
    Clin Exp Rheumatol. 2020;38 Suppl 127:11-16.
    PubMed     Abstract available


  152. IZUKA S, Yamashita H, Takahashi Y, Kaneko H, et al
    Serum aldolase serves as a useful marker for diagnosis and assessment of disease activity in patients with adult-onset Still's disease.
    Clin Exp Rheumatol. 2020;38 Suppl 127:119.
    PubMed    


    August 2020
  153. MATSUOKA Y, Morimoto S, Fujishiro M, Hayakawa K, et al
    Metformin repositioning in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Aug 5. pii: 15643.
    PubMed     Abstract available


    July 2020
  154. BURSKA AN, El-Jawhari JJ, Wu J, Wakefield RJ, et al
    Receptor activator of nuclear factor kappa-Beta ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jul 21. pii: 14765.
    PubMed     Abstract available


  155. MA Y, Hong FF, Yang SL
    Role of prostaglandins in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jul 21. pii: 15463.
    PubMed     Abstract available


  156. SPECKER C, Alberding A, Aringer M, Burmester GR, et al
    ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jul 10. pii: 14616.
    PubMed     Abstract available


  157. KONG R, Gao J, Ji L, Peng Y, et al
    Iguratimod ameliorates rheumatoid arthritis progression through regulating miR-146a mediated IRAK1 expression and TRAF6/JNK1 pathway: an in vivo and in vitro study.
    Clin Exp Rheumatol. 2020 Jul 10. pii: 15134.
    PubMed     Abstract available


  158. PEREIRA DF, Natour J, Ribeiro LHC, Ferreira FBMD, et al
    Painless and painful synovitis have similar ultrasound and clinical outcomes: one-year cohort study in longstanding rheumatoid arthritis women patients.
    Clin Exp Rheumatol. 2020 Jul 10. pii: 15072.
    PubMed     Abstract available


  159. GANDOLFO S, Fabro C, Kapsogeorgou E, Colafrancesco S, et al
    Validation of thymic stromal lymphopoietin as a biomarker of primary Sjogren's syndrome and related lymphoproliferation: results in independent cohorts.
    Clin Exp Rheumatol. 2020;38 Suppl 126:189-194.
    PubMed     Abstract available


  160. ACAR-DENIZLI N, Horvath IF, Mandl T, Priori R, et al
    Systemic phenotype related to primary Sjogren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
    Clin Exp Rheumatol. 2020;38 Suppl 126:85-94.
    PubMed     Abstract available


  161. DE WOLFF L, Arends S, van Nimwegen JF, Bootsma H, et al
    Ten years of the ESSDAI: is it fit for purpose?
    Clin Exp Rheumatol. 2020;38 Suppl 126:283-290.
    PubMed     Abstract available


  162. MACHOWICZ A, Hall I, de Pablo P, Rauz S, et al
    Mediterranean diet and risk of Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:216-221.
    PubMed     Abstract available


  163. MEKINIAN A, Tennenbaum J, Lahuna C, Dellal A, et al
    Primary Sjogren's syndrome: central and peripheral nervous system involvements.
    Clin Exp Rheumatol. 2020;38 Suppl 126:103-109.
    PubMed     Abstract available


  164. FASANO S, Mauro D, Macaluso F, Xiao F, et al
    Pathogenesis of primary Sjogren's syndrome beyond B lymphocytes.
    Clin Exp Rheumatol. 2020;38 Suppl 126:315-323.
    PubMed     Abstract available


  165. DONATI V, Ferro F, Governato G, Fulvio G, et al
    Total area of inflammatory infiltrate and percentage of inflammatory infiltrate identify different clinical-serological subsets of primary Sjogren's syndrome better than traditional histopathological parameters.
    Clin Exp Rheumatol. 2020;38 Suppl 126:195-202.
    PubMed     Abstract available


  166. PONTARINI E, Verstappen GM, Grigoriadou S, Kroese FGM, et al
    Blocking T cell co-stimulation in primary Sjogren's syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers.
    Clin Exp Rheumatol. 2020;38 Suppl 126:222-227.
    PubMed     Abstract available


  167. FERRO F, Izzetti R, Vitali S, Aringhieri G, et al
    Ultra-high frequency ultrasonography of labial glands is a highly sensitive tool for the diagnosis of Sjogren's syndrome: a preliminary study.
    Clin Exp Rheumatol. 2020;38 Suppl 126:210-215.
    PubMed     Abstract available


  168. CHATZAKI C, Goules A, De Vita S, Zabotti A, et al
    A Training Tool to support the management and diagnosis of Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:174-179.
    PubMed     Abstract available


  169. DE LUCIA O, Zandonella Callegher S, De Souza MV, Battafarano N, et al
    Ultrasound assessment of lacrimal glands: a cross-sectional study in healthy subjects and a preliminary study in primary Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2020;38 Suppl 126:203-209.
    PubMed     Abstract available


  170. LUPPI F, Sebastiani M, Silva M, Sverzellati N, et al
    Interstitial lung disease in Sjogren's syndrome: a clinical review.
    Clin Exp Rheumatol. 2020;38 Suppl 126:291-300.
    PubMed     Abstract available


  171. PRIORI R, Mastromanno L, Izzo R
    What about glucocorticoids in primary Sjogren's syndrome?
    Clin Exp Rheumatol. 2020;38 Suppl 126:237-244.
    PubMed     Abstract available


  172. DIEKHOFF T, Fischer T, Schefer Q, Posch MG, et al
    Ianalumab (VAY736) in primary Sjogren's syndrome: assessing disease activity using multi-modal ultrasound.
    Clin Exp Rheumatol. 2020;38 Suppl 126:228-236.
    PubMed     Abstract available


  173. NARVAEZ J, Sanchez-Piedra C, Fernandez-Castro M, Martinez-Taboada V, et al
    Clinically significant renal involvement in primary Sjogren's syndrome is associated with important morbidity: data from the Spanish Sjogrenser cohort.
    Clin Exp Rheumatol. 2020;38 Suppl 126:116-124.
    PubMed     Abstract available


  174. CAFARO G, Perricone C, Baldini C, Quartuccio L, et al
    Significance of anti-La/SSB antibodies in primary Sjogren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy.
    Clin Exp Rheumatol. 2020;38 Suppl 126:53-56.
    PubMed     Abstract available


  175. WANG X, Bootsma H, de Koning J, Kroese FGM, et al
    Novel approaches for rescuing function of the salivary gland epithelium in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:261-270.
    PubMed     Abstract available


  176. STERGIOU IE, Papageorgiou A, Chatzis LG, Tzioufas AG, et al
    T cell lymphoma in the setting of Sjogren's syndrome: T cells gone bad? Report of five cases from a single centre cohort.
    Clin Exp Rheumatol. 2020;38 Suppl 126:125-129.
    PubMed     Abstract available


  177. MELCHOR S, Sanchez-Piedra C, Fernandez Castro M, Andreu JL, et al
    Digestive involvement in primary Sjogren's syndrome: analysis from the Sjogrenser registry.
    Clin Exp Rheumatol. 2020;38 Suppl 126:110-115.
    PubMed     Abstract available


  178. VEHOF J, Utheim TP, Bootsma H, Hammond CJ, et al
    Advances, limitations and future perspectives in the diagnosis and management of dry eye in Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:301-309.
    PubMed     Abstract available


  179. MOSSEL E, Arends S, Bootsma H
    Recent insights in the potential role of imaging modalities for diagnosing patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:310-314.
    PubMed     Abstract available


  180. CARUBBI F, Alunno A, Conforti A, Riccucci I, et al
    Characterisation of articular manifestations in primary Sjogren's syndrome: clinical and imaging features.
    Clin Exp Rheumatol. 2020;38 Suppl 126:166-173.
    PubMed     Abstract available


  181. BRITO-ZERON P, Pasoto SG, Robles-Marhuenda A, Mandl T, et al
    Autoimmune congenital heart block and primary Sjogren's syndrome: characterisation and outcomes of 49 cases.
    Clin Exp Rheumatol. 2020;38 Suppl 126:95-102.
    PubMed     Abstract available


  182. LUCCHESI D, Pontarini E, Donati V, Mandarano M, et al
    The use of digital image analysis in the histological assessment of Sjogren's syndrome salivary glands improves inter-rater agreement and facilitates multicentre data harmonisation.
    Clin Exp Rheumatol. 2020;38 Suppl 126:180-188.
    PubMed     Abstract available


  183. REED JH, Verstappen GM, Rischmueller M, Bryant VL, et al
    When B cells break bad: development of pathogenic B cells in Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:271-282.
    PubMed     Abstract available


  184. BOMBARDIERI M, Argyropoulou OD, Ferro F, Coleby R, et al
    One year in review 2020: pathogenesis of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:3-9.
    PubMed     Abstract available


  185. ALBRECHT K, Dorner T, Redeker I, Karberg K, et al
    Comorbidity and health care utilisation in persons with Sjogren's syndrome: a claims data analysis.
    Clin Exp Rheumatol. 2020;38 Suppl 126:78-84.
    PubMed     Abstract available


  186. PRINGLE S, Wang X, Vissink A, Bootsma H, et al
    Checkpoint inhibition-induced sicca: a type II interferonopathy?
    Clin Exp Rheumatol. 2020;38 Suppl 126:253-260.
    PubMed     Abstract available


  187. MELSENS K, Leone MC, Paolino S, Elewaut D, et al
    Nailfold capillaroscopy in Sjogren's syndrome: a systematic literature review and standardised interpretation.
    Clin Exp Rheumatol. 2020;38 Suppl 126:150-157.
    PubMed     Abstract available


  188. CHEN J, Jin Y, Li C, Gan Y, et al
    Evaluation of soluble CD25 as a clinical and autoimmune biomarker in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:142-149.
    PubMed     Abstract available


  189. LYNE SA, Downie-Doyle S, Lester SE, Quinlivan A, et al
    Primary Sjogren's syndrome in South Australia.
    Clin Exp Rheumatol. 2020;38 Suppl 126:57-63.
    PubMed     Abstract available


  190. MANFRE V, Cafaro G, Riccucci I, Zabotti A, et al
    One year in review 2020: comorbidities, diagnosis and treatment of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:10-22.
    PubMed     Abstract available


  191. PARK Y, Lee J, Koh JH, Choe JY, et al
    Positive histopathologic assessment in salivary glands shows little impact on clinical features of established primary Sjogren's syndrome in a Korean population.
    Clin Exp Rheumatol. 2020;38 Suppl 126:158-165.
    PubMed     Abstract available


  192. CASTREJON-MORALES CY, Granados-Portillo O, Cruz-Bautista I, Ruiz-Quintero N, et al
    Omega-3 and omega-6 fatty acids in primary Sjogren's syndrome: clinical meaning and association with inflammation.
    Clin Exp Rheumatol. 2020;38 Suppl 126:34-39.
    PubMed     Abstract available


  193. APOSTOLOU E, Tzioufas AG
    Type-III interferons in Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:245-252.
    PubMed     Abstract available


  194. SINGH JA, Cleveland JD
    Serious infections in Sjogren's syndrome patients: a national U.S. study.
    Clin Exp Rheumatol. 2020;38 Suppl 126:47-52.
    PubMed     Abstract available


  195. ZAMPELI E, Mavrommati M, Moutsopoulos HM, Skopouli FN, et al
    Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
    Clin Exp Rheumatol. 2020;38 Suppl 126:134-141.
    PubMed     Abstract available


  196. HERNANDEZ-MOLINA G, Avila-Casado C, Hernandez-Hernandez C, Recillas-Gispert C, et al
    Performance of the 2016 ACR/EULAR SS classification criteria in patients with secondary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:130-133.
    PubMed     Abstract available


  197. AHN JK, Hwang J, Seo GH
    Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjogren's syndrome measured using the Korean Health Insurance Claims Database.
    Clin Exp Rheumatol. 2020;38 Suppl 126:40-46.
    PubMed     Abstract available


  198. HAMMITT KM
    Sjogren's: the patients' perspective.
    Clin Exp Rheumatol. 2020;38 Suppl 126:25-26.
    PubMed    


  199. TZIOUFAS AG, Bootsma H, Pers JO
    EULAR Sjogren's syndrome study group: an eSSential way to address the unmet needs of the disease.
    Clin Exp Rheumatol. 2020;38 Suppl 126:23-24.
    PubMed    


  200. CONTICINI E, Sota J, Falsetti P, Bellisai F, et al
    Anti-dense fine speckled 70 antibodies in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:326.
    PubMed    


  201. LA BARBERA L, Grasso G, Rizzo C, Ciccia F, et al
    Colchicine as possible treatment of non-cryoglobulinaemic vasculitis in Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:324-325.
    PubMed    


    June 2020
  202. SELMI C, Kruger K, Cantagrel A, Abad Hernandez MA, et al
    BENEFIT: real-world effectiveness of SB4 after transition from reference etanercept in rheumatoid arthritis and axial spondyloarthritis.
    Clin Exp Rheumatol. 2020 Jun 30. pii: 14829.
    PubMed     Abstract available


  203. SEJOURNET L, Kodjikian L, Grange L, Grumet P, et al
    Resolution of ocular and mediastinal sarcoidosis after Janus kinase inhibitor therapy for concomitant rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jun 30. pii: 15669.
    PubMed    


  204. PONCHEL F, van Delft MAM, Xie X, Burska AN, et al
    Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?
    Clin Exp Rheumatol. 2020 Jun 30. pii: 15082.
    PubMed     Abstract available


  205. KORENDOVYCH V, Fleischhammer J, Tampe B, Nikiphorou E, et al
    Severely destructive unilateral wrist arthritis as a rare variant of rheumatoid arthritis: analysis of clinical and imaging features.
    Clin Exp Rheumatol. 2020 Jun 23. pii: 15392.
    PubMed     Abstract available


  206. KAUNDAL U, Khullar A, Leishangthem B, Jain S, et al
    The effect of methotrexate on neutrophil reactive oxygen species and CD177 expression in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jun 23. pii: 15398.
    PubMed     Abstract available


  207. SANCHEZ-CARDENAS G, Contreras-Yanez I, Mendez-Flores S, Merayo-Chalico J, et al
    Toenail abnormalities in rheumatoid arthritis patients are associated with radiographic damage and impact disability: a cross sectional study nested within a cohort.
    Clin Exp Rheumatol. 2020 Jun 23. pii: 15106.
    PubMed     Abstract available


  208. MANARA M, Caporali R, Lomater C, Gorla R, et al
    Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study.
    Clin Exp Rheumatol. 2020 Jun 19. pii: 14934.
    PubMed     Abstract available


  209. LIU G, Xu D, He Y, Xu J, et al
    Inhibition of transient receptor potential canonical 6 attenuates fibroblast-like synoviocytes mediated synovial inflammation and joint destruction in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jun 12. pii: 15129.
    PubMed     Abstract available


    May 2020
  210. CARREA A, Preisegger MA, Velasco Zamora J, Dewey RA, et al
    The mRNA levels of TGF-beta Type II receptor splice variants in monocytes are associated with disease activity in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 May 20. pii: 15229.
    PubMed     Abstract available


  211. PULITO-CUETO V, Remuzgo-Martinez S, Genre F, Calvo-Alen J, et al
    Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 May 20. pii: 15039.
    PubMed     Abstract available


  212. LI Z, Hu J, Bao C, Li X, et al
    Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.
    Clin Exp Rheumatol. 2020 May 20. pii: 13989.
    PubMed     Abstract available


  213. PABLOS JL, Navarro F, Blanco FJ, Roman-Ivorra JA, et al
    Erratum corrige: "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study". J.L. Pablos et al.
    Clin Exp Rheumatol. 2020;38:585.
    PubMed    


  214. BILIA S, Giannini D, Rizzelli GML, Tavoni A, et al
    Anakinra in COVID-19 therapy: what have we learned from adult-onset Still's disease?
    Clin Exp Rheumatol. 2020;38:579.
    PubMed    


  215. PERRICONE C, Conigliaro P, Ciccacci C, Marcucci E, et al
    The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart.
    Clin Exp Rheumatol. 2020;38:580.
    PubMed    


  216. ELKHIDER A, Wei J, Al-Azab M, Tang Y, et al
    IL-34 modulates rheumatoid synovial fibroblasts proliferation and migration via ERK/AKT signalling pathway.
    Clin Exp Rheumatol. 2020;38:479-487.
    PubMed     Abstract available


  217. MATSUNO H, Katayama K, Funahashi K, Saitoh M, et al
    Choice of the most appropriate biological disease-modifying anti-rheumatic drug for injection spacing: results from a multicentre observational study.
    Clin Exp Rheumatol. 2020;38:398-404.
    PubMed     Abstract available


    April 2020
  218. KUMAR R, Piantoni S, Boldini M, Garrafa E, et al
    Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept.
    Clin Exp Rheumatol. 2020 Apr 27. pii: 15133.
    PubMed     Abstract available


  219. KOH JH, Lee SK, Kim J, Kim HA, et al
    Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry.
    Clin Exp Rheumatol. 2020 Apr 23. pii: 15107.
    PubMed     Abstract available


  220. GIANNINI D, Antonucci M, Petrelli F, Bilia S, et al
    One year in review 2020: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Apr 23. pii: 15504.
    PubMed     Abstract available


  221. PAUL D, Fazeli MS, Mintzer L, Duarte L, et al
    Comparative efficacy and safety of current therapies for early rheumatoid arthritis: a systematic literature review and network meta-analysis.
    Clin Exp Rheumatol. 2020 Apr 17. pii: 14804.
    PubMed     Abstract available


  222. LEE SY, Jung KH, Park SG, Kwon SR, et al
    Obesity potentially protects against systemic bone loss in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors.
    Clin Exp Rheumatol. 2020 Apr 9. pii: 15224.
    PubMed     Abstract available


  223. KRASSELT M, Halbritter J, Amann K, Baerwald C, et al
    ANCA-positive IgA nephropathy in a patient with ANA-positive long-standing rheumatoid arthritis and type 1 diabetes.
    Clin Exp Rheumatol. 2020 Apr 7. pii: 15205.
    PubMed    


  224. ZENG P, Pertsinidou E, Brynedal B, Manivel VA, et al
    Occupational physical workload and development of anti-collagen type II antibodies in rheumatoid arthritis: results from the Swedish EIRA population-based case-control study.
    Clin Exp Rheumatol. 2020 Apr 3. pii: 14118.
    PubMed    


    March 2020
  225. OMETTO F, Fedeli U, Botsios C, Punzi L, et al
    A long-term nationwide study on mortality associated to rheumatoid arthritis in Italy.
    Clin Exp Rheumatol. 2020 Mar 28. pii: 15047.
    PubMed     Abstract available


  226. SIFUENTES-CANTU C, Butron-Hernandez D, Contreras-Yanez I, Pascual-Ramos V, et al
    Musculoskeletal ultrasound to complement clinical evaluation and drive treatment of rheumatoid arthritis patients in remission does not prevent worsening of patient-reported outcomes: the ULTRAPRO randomised controlled study.
    Clin Exp Rheumatol. 2020 Mar 28. pii: 14742.
    PubMed     Abstract available


  227. SILVAGNI E, Giollo A, Sakellariou G, Ughi N, et al
    One year in review 2020: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2020;38:181-194.
    PubMed     Abstract available


  228. GENG Y, Li B, Deng X, Ji L, et al
    Salivary gland ultrasound integrated with 2016 ACR/EULAR classification criteria improves the diagnosis of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38:322-328.
    PubMed     Abstract available


  229. BERKHOUT LC, Vogelzang EH, Hart MM, Loeff FC, et al
    The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisation.
    Clin Exp Rheumatol. 2020;38:306-313.
    PubMed     Abstract available


  230. SOGKAS G, Klose K, Baerlecken N, Schweikhard E, et al
    CD74 is a T cell antigen in spondyloarthritis.
    Clin Exp Rheumatol. 2020;38:195-202.
    PubMed     Abstract available


  231. ZHOU Z, Miao Z, Luo A, Zhu D, et al
    Identifying a marked inflammation mediated cardiac dysfunction during the development of arthritis in collagen-induced arthritis mice.
    Clin Exp Rheumatol. 2020;38:203-211.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: